Amylin Pharmaceuticals, Inc. (AMLN)
$12.44
-0.33 (-2.58%)
| CAPS Rating |
|
|---|---|
| Open | $12.74 |
| Previous Close | $12.77 |
| Daily Range | $12.42 - $12.77 |
| 52-Week Range | $5.50 - $15.69 |
| Market Cap | $1.76B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,358,722 |
| Average Daily Volume | 2,575,000 |
AMLN
VS S&P 500 (SPY)
How do you think AMLN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
AMLN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
AMLN News and Commentary
- You Missed the Best Day to Buy – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- UPDATE 1-Amylin says Byetta gets FDA approval for new use – Reuters
- Top-Rated Stocks That Treat Shareholders Right – The Motley Fool
- Merck-Schering Doesn't Look So Good – The Motley Fool
- 5 Stocks Approaching Greatness – The Motley Fool
- Warning: Potential Blockbuster Ahead – The Motley Fool
- Here We Go Again With Possible Side Effects – The Motley Fool
- Alkermes Needs Some Financial Alchemy – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Elan and J&J, Sitting in a Tree ... – The Motley Fool
- Amgen Falls Back on the Future – The Motley Fool
- The Roller-Coaster Stock That Keeps on Giving – The Motley Fool
- The Slowly Wilting Lilly – The Motley Fool
- The Blockbuster Around the Corner – The Motley Fool
- 3 Stocks Ready to Roar – The Motley Fool
- One-Drug Wonders Deserve a Spot in Your Portfolio – The Motley Fool
- Lantus Results: Reply Hazy, Try Again Later – The Motley Fool
- Rumors and Safety Issues -- One Bad Combination – The Motley Fool
- Looking for a Sliver of the Me-Too Pie – The Motley Fool
RSS Headlines
Fool UK
